Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Barley

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Hematologic Malignancy Reports|February 29, 2016
Diagnostic Advances in Multiple MyelomaKevin Barley, Ajai Chari
Schizophrenia Research|May 19, 2009
Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorderKevin Barley, Stella Dracheva, William Byne
Clinical Lymphoma, Myeloma & Leukemia|October 27, 2012
Safety and efficacy of triplet regimens in newly diagnosed light chain amyloidosisAjai Chari, Kevin Barley, Sundar Jagannath, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 30, 2015
Serum Free Light Chain Assessment Early After Stem Cell Transplantation as a Prognostic Factor in Multiple MyelomaKevin Barley, Sharon Tindle, Emilia Bagiella, et al.
Leukemia & Lymphoma|March 5, 2016
Outcomes and management of lenalidomide-associated rash in patients with multiple myelomaKevin Barley, Wei He, Shradha Agarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Misdiagnosis of non-hodgkin lymphoma as multiple myelomaKevin Barley, Jonathan A Harris, Catherine Diefenbach, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 5, 2009
Editing of serotonin 2C receptor mRNA in the prefrontal cortex characterizes high-novelty locomotor response behavioral traitStella Dracheva, Rebecca Lyddon, Kevin Barley, et al.
Schizophrenia Research|June 29, 2010
Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophreniaDavid Kerns, Ghe S Vong, Kevin Barley, et al.
Clinical Advances in Hematology & Oncology : H&O|December 5, 2017
The effect of novel therapies in high-molecular-risk multiple myelomaGuido Lancman, Douglas Tremblay, Kevin Barley, et al.
Expert Review of Hematology|August 1, 2020
Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based reviewLarysa Sanchez, Kevin Barley, Joshua Richter, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Hematologic Malignancy Reports|February 29, 2016
Diagnostic Advances in Multiple MyelomaKevin Barley, Ajai Chari
Schizophrenia Research|May 19, 2009
Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorderKevin Barley, Stella Dracheva, William Byne
Clinical Lymphoma, Myeloma & Leukemia|October 27, 2012
Safety and efficacy of triplet regimens in newly diagnosed light chain amyloidosisAjai Chari, Kevin Barley, Sundar Jagannath, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 30, 2015
Serum Free Light Chain Assessment Early After Stem Cell Transplantation as a Prognostic Factor in Multiple MyelomaKevin Barley, Sharon Tindle, Emilia Bagiella, et al.
Leukemia & Lymphoma|March 5, 2016
Outcomes and management of lenalidomide-associated rash in patients with multiple myelomaKevin Barley, Wei He, Shradha Agarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Misdiagnosis of non-hodgkin lymphoma as multiple myelomaKevin Barley, Jonathan A Harris, Catherine Diefenbach, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 5, 2009
Editing of serotonin 2C receptor mRNA in the prefrontal cortex characterizes high-novelty locomotor response behavioral traitStella Dracheva, Rebecca Lyddon, Kevin Barley, et al.
Schizophrenia Research|June 29, 2010
Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophreniaDavid Kerns, Ghe S Vong, Kevin Barley, et al.
Clinical Advances in Hematology & Oncology : H&O|December 5, 2017
The effect of novel therapies in high-molecular-risk multiple myelomaGuido Lancman, Douglas Tremblay, Kevin Barley, et al.
Expert Review of Hematology|August 1, 2020
Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based reviewLarysa Sanchez, Kevin Barley, Joshua Richter, et al.
Pageof 2